name: Business team
members:
  - name-en: Takeshi Akatsu, PhD, Patent Attorney
    name-jp: 赤津 豪 博士（工学）、付記弁理士
    title-en: 
    title-jp: 
    image: /assets/img/team/team_akatsu.png
    about-en: >
              Takashi has some ten years’ experience in materials science as a researcher at the Max Planck Institutes of Metal Research and Microstructure Physics (Germany) and as an R&amp;D project leader for advanced substrate development at SOITEC (France). In Japan, he worked in IP law firms. He therefore brings a profound knowledge of R&amp;D and IP to his role as director of IP and BD at Quantum Biosystems. He was awarded a doctorate in Precision Machinery Engineering by the University of Tokyo. 

    about-jp: >
              知財・事業開発部長。専門分野は材料科学。マックスプランク研究所金属材料研究所、同微細構造物理研究所（ドイツ）を経て、SOITEC社（フランス）で、プロジェクトリーダーとして次世代半導体基板の研究開発に従事。半導体のR&amp;Dと知財の双方の深い知識でQB社の知財構築と事業開発に当たる。東大工学部精密機械工学科卒、同博士過程修了。英語、ドイツ語、フランス語に堪能。 

  - name-en: Masau Takayanagi, Patent Attorney
    name-jp: 高柳 昌生 (弁理士)
    title-en: 
    title-jp: 
    image: /assets/img/team/team_takayanagi.png
    about-en: >
              Masau has more than forty years’ experience in IP management. In 2012, he established Takayanagi IP Management after working as an executive officer and director of IP at Kyowa Kirin. He is also a representative of the Licensing Executives Society Japan and teaches classes focused on pharmaceutical IP at several universities in Japan. He was an executive board member and head of the IP Department at Mitsubishi Pharma Corporation and a vice chairman of the Japan Pharmaceutical Manufacturers Association (JPMA) Intellectual Committee.

    about-jp: >
              IPマネジメントに関して40年以上の経験を持つ。<br> 三菱ウェルファーマ、協和発酵キリン株執行役員・知的財産部長などを経て、高柳IPマネジメントを設立。日本製薬工業協会知的財産委員会・副委員長 、内閣府「ライフサイエンス分野における知的財産の保護・活用等に関する検討プロジェクトチーム」メンバー、日本ライセンス協会会長(LES International 日本代表)などを歴任した他、国立・私立大学などで製薬・知財関連の講座も担当している。

  - name-en: Akira Usui
    name-jp: 臼井 玲
    title-en: 
    title-jp: 
    image: /assets/img/team/team_usui.png
    about-en: >
              Akira has more than twenty years’ experience of licensing, business development and alliance management in the pharmaceutical industry. He worked at Roche as a director of business development in the Pharmaceutical Division, mainly focused on the Asia-Pacific region, and established Roche Pharma’s Japan office. He was also representative director and general manager at Perlegen Sciences Japan and a vice president at its parent company in the US. Pergelen was established to identify patterns of genetic variation between individuals, information which was then used to improve patient care and discover the genetic foundations of diseases. In 2007, he founded Ray Life Sciences Inc., and he has worked as an external board director for a number of biotechnology venture companies.

    about-jp: >
              製薬業界におけるライセンシング、事業開発、業務提携に関しての20年以上の経験を持つ。田辺製薬、日本ロシュを経て、スイス・ロシュ本社医薬品部門ビジネスデベロップメントディレクター(日本・アジア担当)に就任。また、(遺伝子情報の識別によるパーソナルメディシン開発を目的とした) パーレジェンサイエンス・ジャパン代表取締役、米国本社副社長。
              現在はレイライフサイエンスを設立し、バイオベンチャーの社外取締役を歴任。

  - name-en: Li Jin Sajo
    name-jp: Li Jin Sajo
    title-en: 
    title-jp: 
    image: /assets/img/team/team_li.png
    about-en: >
              Li conducted research on DNA methylation in the Department of Pharmaceutical Science at the University of Tokyo’s Graduate School. Quantum Biosystems utilizes his technical knowledge in this field. He has also worked with clients in the pharmaceutical industry as a consultant at McKinsey &amp; Company. He is currently pursuing an MBA at Stanford’s Graduate School of Business.

    about-jp: >
              東京大学薬学部修士課程修了。<br>
              専門はDNAのメチル化分析。<br>
              McKinsey &amp; Companyにて、コンサルタントとして、グローバル製薬企業のプロジェクトに従事。2013年9月よりスタンフォード大学ビジネススクールにてMBA取得のため留学中。


  - name-en: Takuma Nakatsuka
    name-jp: 中塚琢磨
    image: /assets/img/team/team_nakatsuka.png
    about-en: >
              Takuma has extensive management experience in pharma/ biotechnology industries, including as CFO of NanoCarrier (DDS/nanotechnology), AnGes-MG (gene therapy) and Nihon-Schering, as well as CEO of GenoMedia (gene therapy). He also has over 15 years of management experience in manufacturing and service industries such as Hosokawa Micron (nanotechnology), Veolia-Water Japan and Nishihara Environment Technology (engineering). His career started in public service right after graduation from the University of Tokyo (law). His graduate studies were in public policy and economics at the University of Michigan before he was awarded an MBA (finance and strategic management) from Wharton School, the University of Pennsylvania.

    about-jp: >
              ナノキャリア（株）、アンジェスＭＧ（株）、（株）日本シェーリングでＣＦＯや常務取締役を、また、ジェノミデイア（株）で代表取締役社長を勤めるなど、医薬・バイオ分野で幅広い経営の経験を積んできている。これ以外にもホソカワミクロン（株）、（株）ヴェオリアウオーター・ジャパン、西原環境テクノジー（株）などで企業経営に携わっており、製造業及びサービス業を通して15年を超える企業経営の経験を有している。 東京大学法学部卒（国家公務員）。米国ミシガン大学修士（公共政策、経済学）、ペンシルバニア大学ウオートンスクール経営学修士（企業戦略及び財務）。

